DVAX - Dynavax Technologies Corporation Stock Trading

Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021 PR Newswire EMERYVILLE, Calif. , July 21, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on d...

Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate Biological E to purchase CpG 1018 adjuvant from Dynavax for use in the commercial production of Biological E's COVID-19 vaccine candidate, C...

Shares of Dynavax Technologies (NASDAQ: DVAX) were up by 11.2% so far this week as of the market close on Thursday. That gain was primarily due to the company's announcement on Wednesday that it had signed an agreement with Clover Biopharmaceuticals under which it will supply its Cp...